The Origin and Biomedical Relevance of Cannabigerol
The constant search for new pharmacologically active compounds, especially those that do not exhibit toxic effects, intensifies the interest in plant-based ingredients and their potential use in pharmacotherapy. One of the plants that has great therapeutic potential is <i>Cannabis sativa</i...
Main Authors: | Anna Jastrząb, Iwona Jarocka-Karpowicz, Elżbieta Skrzydlewska |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-07-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/14/7929 |
Similar Items
-
Determining Antioxidant Activity of Cannabis Leaves Extracts from Different Varieties—Unveiling Nature’s Treasure Trove
by: Anna Stasiłowicz-Krzemień, et al.
Published: (2023-07-01) -
In Vitro and Clinical Evaluation of Cannabigerol (CBG) Produced via Yeast Biosynthesis: A Cannabinoid with a Broad Range of Anti-Inflammatory and Skin Health-Boosting Properties
by: Eduardo Perez, et al.
Published: (2022-01-01) -
Anti-Biofilm Activity of Cannabigerol against <i>Streptococcus mutans</i>
by: Muna Aqawi, et al.
Published: (2021-09-01) -
Biotechnological Approaches on Two High CBD and CBG <i>Cannabis sativa</i> L. (Cannabaceae) Varieties: In Vitro Regeneration and Phytochemical Consistency Evaluation of Micropropagated Plants Using Quantitative <sup>1</sup>H-NMR
by: Kostas Ioannidis, et al.
Published: (2020-12-01) -
Cannabidiol and Cannabigerol Inhibit Cholangiocarcinoma Growth In Vitro via Divergent Cell Death Pathways
by: Michael J. Viereckl, et al.
Published: (2022-06-01)